published that the development of CML occurred no less than 10 and up to 36 years after the diagnosis of BCR::ABL1-negative MPN [17], whereas in our study, 0.7–20.0 years elapsed between the diagnoses of both MPNs. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.